Details for New Drug Application (NDA): 021514
✉ Email this page to a colleague
NDA 021514 describes DAYTRANA, which is a drug marketed by Noven Pharms Inc and is included in one NDA. It is available from two suppliers. Additional details are available on the DAYTRANA profile page.
The generic ingredient in DAYTRANA is methylphenidate. There is one drug master file entry for this compound. Five suppliers are listed for this compound. Additional details are available on the methylphenidate profile page.
The generic ingredient in DAYTRANA is methylphenidate. There is one drug master file entry for this compound. Five suppliers are listed for this compound. Additional details are available on the methylphenidate profile page.
Summary for 021514
| Tradename: | DAYTRANA |
| Applicant: | Noven Pharms Inc |
| Ingredient: | methylphenidate |
| Patents: | 0 |
Pharmacology for NDA: 021514
| Physiological Effect | Central Nervous System Stimulation |
Medical Subject Heading (MeSH) Categories for 021514
Suppliers and Packaging for NDA: 021514
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| DAYTRANA | methylphenidate | FILM, EXTENDED RELEASE;TRANSDERMAL | 021514 | NDA AUTHORIZED GENERIC | PADAGIS US LLC | 0574-2410 | 0574-2410-65 | 1 TRAY in 1 CARTON (0574-2410-65) / 30 POUCH in 1 TRAY / 1 PATCH in 1 POUCH / 27.5 mg in 1 PATCH |
| DAYTRANA | methylphenidate | FILM, EXTENDED RELEASE;TRANSDERMAL | 021514 | NDA AUTHORIZED GENERIC | PADAGIS US LLC | 0574-2415 | 0574-2415-65 | 1 TRAY in 1 CARTON (0574-2415-65) / 30 POUCH in 1 TRAY / 1 PATCH in 1 POUCH / 41.3 mg in 1 PATCH |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | FILM, EXTENDED RELEASE;TRANSDERMAL | Strength | 10MG/9HR (1.1MG/HR) | ||||
| Approval Date: | Apr 6, 2006 | TE: | AB | RLD: | Yes | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | FILM, EXTENDED RELEASE;TRANSDERMAL | Strength | 15MG/9HR (1.6MG/HR) | ||||
| Approval Date: | Apr 6, 2006 | TE: | AB | RLD: | Yes | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | FILM, EXTENDED RELEASE;TRANSDERMAL | Strength | 20MG/9HR (2.2MG/HR) | ||||
| Approval Date: | Apr 6, 2006 | TE: | AB | RLD: | Yes | ||||
Expired US Patents for NDA 021514
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Noven Pharms Inc | DAYTRANA | methylphenidate | FILM, EXTENDED RELEASE;TRANSDERMAL | 021514-004 | Apr 6, 2006 | ⤷ Start Trial | ⤷ Start Trial |
| Noven Pharms Inc | DAYTRANA | methylphenidate | FILM, EXTENDED RELEASE;TRANSDERMAL | 021514-003 | Apr 6, 2006 | ⤷ Start Trial | ⤷ Start Trial |
| Noven Pharms Inc | DAYTRANA | methylphenidate | FILM, EXTENDED RELEASE;TRANSDERMAL | 021514-001 | Apr 6, 2006 | ⤷ Start Trial | ⤷ Start Trial |
| Noven Pharms Inc | DAYTRANA | methylphenidate | FILM, EXTENDED RELEASE;TRANSDERMAL | 021514-004 | Apr 6, 2006 | ⤷ Start Trial | ⤷ Start Trial |
| Noven Pharms Inc | DAYTRANA | methylphenidate | FILM, EXTENDED RELEASE;TRANSDERMAL | 021514-002 | Apr 6, 2006 | ⤷ Start Trial | ⤷ Start Trial |
| Noven Pharms Inc | DAYTRANA | methylphenidate | FILM, EXTENDED RELEASE;TRANSDERMAL | 021514-002 | Apr 6, 2006 | ⤷ Start Trial | ⤷ Start Trial |
| Noven Pharms Inc | DAYTRANA | methylphenidate | FILM, EXTENDED RELEASE;TRANSDERMAL | 021514-002 | Apr 6, 2006 | ⤷ Start Trial | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription
